Sign in

NCT07494461Not yet recruiting

Inhibitory Control and Gait Adaptability in Parkinson's Disease

Relationship Between Inhibitory Control and Gait Adaptability During Obstacle Crossing in People With Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 27 Mar 2026

Brief summary (registry, in English)

People with Parkinson's disease (PD) may have difficulty stopping or changing their movements, especially when walking around obstacles. The goal of this observational study is to learn if a specific cognitive function, called inhibitory control (the ability to stop or control actions) is associated with gait adaptability in people with Parkinson's disease. Gait adaptability means the ability to adjust how a person walks in response to changes in the environment, such as stepping over obstacles. The main questions the study aims to answer are: * If brain activation related to inhibitory control, measured by EEG, is associated with gait adaptability during obstacle crossing in people with Parkinson's disease? * If behavioral inhibitory control is associated with gait adaptability during obstacle crossing in people with Parkinson's disease? Participants take part in one study visit. During this visit, participants complete simple thinking tests, have their brain activity recorded using EEG, and perform walking tasks that include stepping over obstacles.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
50 (estimated)
First submitted
20 Mar 2026
Start date
1 Apr 2026
Primary completion date
31 Aug 2029
Lead sponsor
National Yang Ming Chiao Tung University
NCT number
NCT07494461

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From 1 Apr 2026 to the primary completion date, 31 Aug 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • The presence of any neurological, musculoskeletal, or cardiovascular disorders that could affect participation in this study;
  • The presence of psychiatric disorders that could interfere with the ability to follow instructions or comply with study procedures;
  • A history of brain surgery, such as deep brain stimulation (DBS)

Who the study is looking for

  • A clinical diagnosis of idiopathic Parkinson's disease;
  • Stable use of prescribed antiparkinsonian medication for at least two weeks;
  • Modified Hoehn and Yahr stage I to III;
  • Age between 18 and 80 years;
  • Ability to ambulate independently for at least 30 meters without assistive devices;
  • A Mini-Mental State Examination (MMSE) score of ≥ 24;
  • Corrected vision and hearing sufficient to effectively receive external stimuli

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
National Yang Ming Chiao Tung University
Coordinator of this site? Confirm its status
TaipeiTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.